- Luminex (NASDAQ:LMNX) Q2 results:
- Total revenue: $109.5M (+31.8%); Assays: $61.2M (+94.9%). Sales growth driven by demand for pandemic-related tests.
- Net income: $12.5M (+355.1%); EPS: $0.27 (+345.5%).
- Cash flow ops: $31.3M (+430.5%).
- Q3 guidance: Revenue: at least $100M (+26%). Consensus: $107M.
- 2020 guidance: Revenue: at least $415M (+24%). Consensus: $387M.
- Shares up 3% after hours.
- Luminex EPS beats by $0.17, beats on revenue